Ticker > Company >

Kronox Lab Sciences share price

Kronox Lab Sciences Ltd.

NSE: KRONOX BSE: 544187 SECTOR: Chemicals  21k   29   3

161.15
-2.10 (-1.29%)
BSE: 21 Nov 04:00 PM

Price Summary

Today's High

₹ 165.3

Today's Low

₹ 158.75

52 Week High

₹ 200.55

52 Week Low

₹ 138

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

597.93 Cr.

Enterprise Value

594.29 Cr.

No. of Shares

3.71 Cr.

P/E

28

P/B

7.75

Face Value

₹ 10

Div. Yield

0.31 %

Book Value (TTM)

₹  20.79

CASH

3.64 Cr.

DEBT

0 Cr.

Promoter Holding

74.21 %

EPS (TTM)

₹  5.75

Sales Growth

-5.98%

ROE

38.45 %

ROCE

51.52%

Profit Growth

30.17 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-5.98%
3 Year12.89%
5 YearNA

Profit Growth

1 Year30.17%
3 Year29.95%
5 YearNA

ROE%

1 Year38.45%
3 Year39.19%

ROCE %

1 Year51.52%
3 Year52.82%

Debt/Equity

0

Price to Cash Flow

34.33

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 74.21 0.00
Jun 2024 74.21 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 29.9482676158058% for the Past 3 years.
  • Company has been maintaining healthy ROE of 39.1922333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 52.8231666666667% over the past 3 years.
  • Company is virtually debt free.
  • Company’s PEG ratio is 0.928428640764961.
  • The company has an efficient Cash Conversion Cycle of 55.0023 days.
  • Company has a healthy liquidity position with current ratio of 6.0745.
  • The company has a high promoter holding of 74.21%.
  • Promoter stake has increased from 0% to 74.21% in the last 1 quarter.

 Limitations

  • The company has shown a poor revenue growth of 12.8906961667237% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024
Net Sales 22.18 25.19 24.86
Total Expenditure 14.32 16.99 16.06
Operating Profit 7.86 8.21 8.8
Other Income 0.83 0.43 0.36
Interest 0 0 0
Depreciation 0.29 0.33 0.34
Exceptional Items 0 0 0
Profit Before Tax 8.4 8.31 8.82
Tax 2.51 2.16 2.35
Profit After Tax 5.88 6.15 6.47
Adjusted EPS (Rs) 1.59 1.66 1.74

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 62.46 82.25 95.58 89.86
Total Expenditure 47.66 62.55 73.87 61.55
Operating Profit 14.8 19.7 21.71 28.32
Other Income 0.78 1.09 1.92 1.58
Interest 0.38 0.41 0.09 0
Depreciation 1.98 2.03 1.5 1.29
Exceptional Items 0 0 0 0
Profit Before Tax 13.22 18.36 22.04 28.61
Tax 3.49 4.73 5.64 7.26
Net Profit 9.73 13.63 16.4 21.35
Adjusted EPS (Rs.) 2.49 3.49 4.42 5.75

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 0.24 0.24 37.1 37.1
Total Reserves 26.57 40.11 7.65 29.2
Borrowings 0 0.47 0 0
Other N/C liabilities 2.65 1.87 0.15 -0.36
Current liabilities 7.94 13.76 8.8 7.67
Total Liabilities 37.41 56.46 53.69 73.61
Assets
Net Block 9.19 11.3 15.91 26.41
Capital WIP 0.4 0 0 0.49
Intangible WIP 0 0 0 0
Investments 0.03 0.03 0.03 0.03
Loans & Advances 1.58 0.98 0.07 0.1
Other N/C Assets 0 0 3.5 0
Current Assets 26.22 44.16 34.18 46.6
Total Assets 37.41 56.46 53.69 73.61
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 13.22 18.36 22.04 28.61
Adjustment 2.19 2.33 1.18 0.54
Changes in Assets & Liabilities -0.54 -6.88 2.17 -4.38
Tax Paid -3.56 -4.79 -5.72 -7.35
Operating Cash Flow 11.31 9.02 19.66 17.42
Investing Cash Flow -2.96 -7.6 -6.6 -17.31
Financing Cash Flow -7.1 -0.67 -13.4 0
Net Cash Flow 1.26 0.76 -0.33 0.1

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024%
promoters 74.21 74.21
jogindersingh g jaswal 26.39 26.39
ketan vinodchandra ramani... 26.39 26.39
ramani pritesh v 21.40 21.40
PARTICULARS Jun 2024% Sep 2024%
investors 25.79 25.79
negen undiscovered value ... 1.71 1.71
capri global capital limi... 1.09 -
chanakya opportunities fu... 1.51 -
minerva emerging opportun... 1.48 -
moneywise financial servi... 1.09 -
vpk global ventures fund ... 1.09 -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Kronox Lab Sciences Stock Price Analysis and Quick Research Report. Is Kronox Lab Sciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Kronox Lab Sciences stock price today is Rs 160.36. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Kronox Lab Sciences . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Kronox Lab Sciences has a PE ratio of 27.8673710551926 which is high and comparatively overvalued .

  • Share Price: - The current share price of Kronox Lab Sciences is Rs 160.36. One can use valuation calculators of ticker to know if Kronox Lab Sciences share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Kronox Lab Sciences has ROA of 33.5434 % which is a good sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Kronox Lab Sciences has a Current ratio of 6.0745 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Kronox Lab Sciences has a ROE of 38.4515 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Kronox Lab Sciences has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Kronox Lab Sciences has reported revenue growth of -5.9799 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Kronox Lab Sciences for the current financial year is 31.5109545260309 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Kronox Lab Sciences is Rs 0.5 and the yield is 0.3119 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Kronox Lab Sciences is Rs 5.7544 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Kronox Lab Sciences in Ticker for free. Also, one can get the intrinsic value of Kronox Lab Sciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Kronox Lab Sciences
X